Company profile: Schrödinger
1.1 - Company Overview
Company description
- Provider of physics-based molecular discovery and design software platforms for therapeutics and materials research, supporting biopharmaceutical and industrial companies, academic institutions, and government labs; offers collaborative and wholly-owned drug discovery programs and pipeline, educational resources and courses, and tools to model and optimize metals, alloys, and ceramics via computational workflows and machine learning.
Products and services
- Life Science: A computational platform that discovers and optimizes molecules to develop better therapeutics for biopharmaceutical applications, enabling research across academic institutions and government laboratories
- Materials Science: A molecular-level platform that discovers, optimizes, and formulates advanced materials at the molecular level for industrial companies, academic institutions, and government laboratories engaged in materials research
- Physics-based Software Platform for Molecular Discovery & Design: A physics-based platform that uses modeling to discover and engineer molecules for therapeutics and materials research across biopharmaceutical and industrial contexts
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Schrödinger
Albert Labs
HQ: Canada
Website
- Description: Provider of pharmaceutical drug development services focused on mental health, pursuing regulatory approval for active compounds. Offerings include KRN-101, a natural psilocybin medicine for cancer-related anxiety; psychedelic-assisted therapy training for mental health professionals; and real-world evidence studies to accelerate development and access of mental health medicines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Albert Labs company profile →
Massive Bio
HQ: United States
Website
- Description: Provider of an AI-powered oncology platform that connects cancer patients to clinical trials and enables pharma to access patients. Offers SYNERGY-AI clinical trial matching, AskFiona and DrArturo AI chatbots, telehealth consultations, genomics analysis for personalized treatment, and concierge services to help patients navigate care and trial options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Massive Bio company profile →
Laetus
HQ: Germany
Website
- Description: Provider of inline quality control and track & trace systems, including serialization, aggregation, and traceability, plus packaging execution systems and vision inspection solutions (ARGUS, POLYPHEM, INSPECT) to ensure packaging accuracy, product integrity verification, supply chain transparency, counterfeit protection, recall efficiency, and efficient returns.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Laetus company profile →
Q2 Metrics
HQ: Canada
Website
- Description: Provider of big-data predictive health analytics with SaaS and DaaS offerings to the healthcare industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q2 Metrics company profile →
Wolflabs
HQ: United Kingdom
Website
- Description: Provider of laboratory equipment via a predominantly web-based platform, offering immediate access to market-priced product information and value for money.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wolflabs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Schrödinger
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Schrödinger
2.2 - Growth funds investing in similar companies to Schrödinger
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Schrödinger
4.2 - Public trading comparable groups for Schrödinger
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →